NervGen Pharma Corp. (NGEN)
NASDAQ: NGEN · Real-Time Price · USD
4.190
-0.170 (-3.90%)
Apr 2, 2026, 11:25 AM EDT - Market open
NervGen Pharma Market Cap
NervGen Pharma has a market cap or net worth of $333.73 million as of April 2, 2026. Its market cap has increased by 147.81% in one year.
Market Cap
333.73M
Enterprise Value
339.14M
1-Year Change
147.81%
Ranking
Category
Stock Price
$4.19
Market Cap Chart
Since April 3, 2019, NervGen Pharma's market cap has increased from $37.43M to $333.73M, an increase of 791.62%. That is a compound annual growth rate of 36.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 347.27M | -22.09% |
| Dec 31, 2025 | 445.73M | 190.81% |
| Dec 31, 2024 | 153.27M | 26.05% |
| Dec 29, 2023 | 121.60M | 74.14% |
| Dec 30, 2022 | 69.83M | -27.73% |
| Dec 31, 2021 | 96.62M | 58.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 3, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rezolute | 316.81M |
| Neurogene | 313.98M |
| Cabaletta Bio | 299.46M |
| Ovid Therapeutics | 292.76M |
| Palisade Bio | 290.30M |
| LENZ Therapeutics | 286.89M |
| Inhibikase Therapeutics | 286.31M |
| Anavex Life Sciences | 284.50M |